ConductScience.org, home

Paper791682

The specific site of tunicamycin inhibition in the formation of dolichol-bound N-acetylglucosamine derivatives.

Lehle L and 1 other. FEBS Lett, 1976. Cited by 325 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The specific site of tunicamycin inhibition in the formation of dolichol-bound N-acetylglucosamine derivatives. Papers, record 791682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/791682

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The specific site of tunicamycin inhibition in the formation of dolichol-bound N-acetylglucosamine derivatives.
PubMed
Journal
FEBS Lett
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
325
iCite
Relative citation ratio, by iCite
7.25
iCite
Revised in PubMed
2019-12-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Lehle LL
2Tanner WW

Source PubMed

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AcetylglucosamineMajor topic
Anti-Bacterial AgentsMajor topic
DiterpenesMajor topic
DolicholsMajor topic
GlucosamineMajor topic
Organophosphorus CompoundsMajor topic
Saccharomyces cerevisiae

Source PubMed

Cited by99

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 325 citations.

PMIDTitleJournalYearIn PapersSource
39,212,382Activation of ATF3 via the integrated stress response pathway regulates innate immune response to restrict Zika virus.J Virol2024https://conductscience.org/library/papers/39212382PubMed
38,963,344Impaired myoblast differentiation and muscle IGF-1 receptor signaling pathway activation after N-glycosylation inhibition.FASEB J2024https://conductscience.org/library/papers/38963344PubMed
38,877,016Development of a natural product optimization strategy for inhibitors against MraY, a promising antibacterial target.Nat Commun2024https://conductscience.org/library/papers/38877016PubMed
37,546,954Activation of ATF3 via the Integrated Stress Response Pathway Regulates Innate Immune Response to Restrict Zika Virus.bioRxiv2024https://conductscience.org/library/papers/37546954PubMed
37,190,766Structure-Based Insight on the Mechanism of N-Glycosylation Inhibition by Tunicamycin.Mol Cells2023https://conductscience.org/library/papers/37190766PubMed
36,467,541Small molecule inhibitors of mammalian glycosylation.Matrix Biol Plus2022https://conductscience.org/library/papers/36467541PubMed
36,157,785
Intermolecular Interactions of Nucleoside Antibiotic Tunicamycin with On-Target MraYCB-TUN and Off-Target DPAGT1-TUN in the Active Sites Delineated by Quantum Mechanics/Molecular Mechanics Calculations.
ACS Omega2022https://conductscience.org/library/papers/36157785PubMed
34,373,5863-Ketodihydrosphingosine reductase maintains ER homeostasis and unfolded protein response in leukemia.Leukemia2022https://conductscience.org/library/papers/34373586PubMed
33,429,911N-Glycosylation in Piroplasmids: Diversity within Simplicity.Pathogens2021https://conductscience.org/library/papers/33429911PubMed
33,404,015Identification and characterization of enzymes involved in the biosynthesis of pyrimidine nucleoside antibiotics.Nat Prod Rep2021https://conductscience.org/library/papers/33404015PubMed
32,877,278Endoplasmic reticulum stress causes insulin resistance by inhibiting delivery of newly synthesized insulin receptors to the cell surface.Mol Biol Cell2020https://conductscience.org/library/papers/32877278PubMed
32,743,134Priming and elongation of chitin chains: Implications for chitin synthase mechanism.Cell Surf2019https://conductscience.org/library/papers/32743134PubMed
30,608,666Folding and Misfolding of Human Membrane Proteins in Health and Disease: From Single Molecules to Cellular Proteostasis.Chem Rev2019https://conductscience.org/library/papers/30608666PubMed
29,459,785GlcNAc-1-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation.Nat Struct Mol Biol2018https://conductscience.org/library/papers/29459785PubMed
29,209,212Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction.Front Pharmacol2017https://conductscience.org/library/papers/29209212PubMed
29,042,410H+ and Pi Byproducts of Glycosylation Affect Ca2+ Homeostasis and Are Retrieved from the Golgi Complex by Homologs of TMEM165 and XPR1.G3 (Bethesda)2017https://conductscience.org/library/papers/29042410PubMed
28,027,591TM6SF2 rs58542926 impacts lipid processing in liver and small intestine.Hepatology2017https://conductscience.org/library/papers/28027591PubMed
26,496,683XBP1s Links the Unfolded Protein Response to the Molecular Architecture of Mature N-Glycans.Chem Biol2015https://conductscience.org/library/papers/26496683PubMed
24,742,667Protein N-glycosylation in oral cancer: dysregulated cellular networks among DPAGT1, E-cadherin adhesion and canonical Wnt signaling.Glycobiology2014https://conductscience.org/library/papers/24742667PubMed
24,233,741Cell-cycle arrest of plant suspension cultures by tunicamycin.Planta1986https://conductscience.org/library/papers/24233741PubMed

See all 99 cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/791682

GET https://conductscience.org/api/papers/v1/791682/cited_by?page=2